Download Immunization Insurance Coverage and Processing 
Pharmacy Times
JULY 16, 2025
That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.
Pharmaceutical Technology
JULY 23, 2025
The legislation also supports the use of mobile manufacturing units, offering close-to-home treatment for patients too unwell to travel, or whose weakened immune systems mean hospital visits carry extra risk. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. You will receive an email shortly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 11, 2025
Most MTM platforms use health plan adjudication data, allowing pharmacists to see any medication billed through the patient’s insurance, even if it was not filled at their pharmacy. Because documentation of medication lists is a key component of MTM, pharmacists are well positioned to incorporate this into transitions of care.”
Pharmacy Times
JULY 22, 2025
These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. PBMs negotiate prices, establish formularies, and process claims, while also creating preferred networks of pharmacies. Additionally, the role of pharmacy benefit managers (PBMs) cannot be overlooked.
Pharmaceutical Technology
AUGUST 12, 2025
Sartorius Stedim Biotech has agreed to invest $3m in Nanotein Technologies, a US-based company engaged in the development of advanced immune cell activation reagents. However, developers encounter several challenges during this process, including dependence on feeder cells and variability in yields. Credit: New Africa/Shutterstock.com.
Pharmaceutical Technology
JUNE 23, 2025
June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Credit: luchschenF /Shutterstock.
Pharmacy Times
JUNE 16, 2025
The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes.
Expert insights. Personalized for you.
Let's personalize your content